BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34961494)

  • 1. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Surg; 2021 Dec; 21(1):441. PubMed ID: 34961494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy.
    Wang P; Zhou S; Zhou H; Liang J; Zhou Z
    Colorectal Dis; 2019 Jul; 21(7):791-796. PubMed ID: 30801862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications.
    Zhou S; Jiang Y; Pei W; Zhou H; Liang J; Zhou Z
    J Surg Oncol; 2021 Sep; 124(3):354-360. PubMed ID: 33882149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
    Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
    BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
    Zhou S; Jiang Y; Liang J; Liu Q
    World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic Benefit of Adjuvant Therapy in Lateral Pelvic Lymph Node Metastasis following Neoadjuvant Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection.
    Jiang YJ; Zhou SC; Chen JH; Liang JW
    J Cancer; 2022; 13(13):3427-3433. PubMed ID: 36313037
    [No Abstract]   [Full Text] [Related]  

  • 10. Establishing and validating predictive nomograms for lateral pelvic lymph node metastasis in patients with rectal cancer based on radiologic factors and clinicopathologic characteristics.
    Zhou S; Yang Y; Lou Z; Liang J; Wang X; Tang J; Liu Q;
    Eur J Surg Oncol; 2023 Apr; 49(4):747-754. PubMed ID: 36604232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
    Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
    Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
    Sinukumar S; Engineer R; Saklani A
    Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China.
    Zhou S; Tang J; Liang J; Lou Z; Fu W; Feng B; Yang Y; Xiao Y; Liu Q
    Front Oncol; 2022; 12():916285. PubMed ID: 36033473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and prognostic significance of postoperative complications following lateral pelvic lymph node dissection for rectal cancer: results of the multicenter lateral node study in China.
    Zhou S; Tang J; Mei S; Lou Z; Fu W; Feng B; Yang Y; Sun Y; Liu Q;
    Jpn J Clin Oncol; 2022 Oct; 52(10):1150-1158. PubMed ID: 35858237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
    Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
    World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy.
    Sakamoto W; Ohki S; Onozawa H; Okayama H; Endo H; Fujita S; Saito M; Saze Z; Momma T; Takenoshita S; Kono K
    J Anus Rectum Colon; 2021; 5(2):129-136. PubMed ID: 33937552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
    Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
    J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
    Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
    Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.